CB
LGND icon

Commerce Bank’s Ligand Pharmaceuticals LGND Stock Holding History

Commerce Bank’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$360K Buy
1,802
+494
+38% +$97.7K ﹤0.01% 1060
2025
Q4 		$247K Buy
+1,308
New +$251K ﹤0.01% 1146

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Commerce Bank's LGND Position: Q1 2026 in Review

Commerce Bank increased its Ligand Pharmaceuticals (LGND) stake by 38% in Q1 2026, buying an estimated $97.7K and bringing the position to 1,802 shares worth $360K. The position accounts for ﹤0.01% of the portfolio, ranked #1060.

Commerce Bank first reported a position in LGND in Q4 2025 and has held it in 2 quarters since. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Commerce Bank held 1,802 shares of Ligand Pharmaceuticals worth $360K as of Q1 2026.
  • Commerce Bank bought 494 Ligand Pharmaceuticals shares in Q1 2026, an estimated $97.7K.
  • Ligand Pharmaceuticals made up ﹤0.01% of Commerce Bank's portfolio in Q1 2026, its #1060 holding.
  • Commerce Bank first reported a position in Ligand Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Commerce Bank's 13F filing for Q1 2026, filed 11 May 2026.